Literature DB >> 23765378

Mucin-type glycopeptide structure in solution: past, present, and future.

Joseph J Barchi1.   

Abstract

Mucins are very high molecular weight glycoproteins that form a "mucus" barrier at the surface of epithelial cells. They are heavily glycosylated with O-linked glycans that are involved in myriad cellular functions, including protection from external changes in pH, ion flux and reactive oxygen species. Aberrations in mucin expression and their glycan constitution have been associated with many disease states including gastritis, pulmonary disorders and cancer. High resolution structural information on mucins is lacking due to their complexity, in particular their large size and the many variants of O-linked glycans produced in their biosynthesis. This review discusses the structures of glycopeptides that contain "mucin-type" glycosylation, and concentrates primarily on data obtained by NMR spectroscopy. The effect of the glycan on the peptide backbone, the features that have shown to be common to this type of glycosylation and the differences of glycosylation at serine and threonine residues are the major topics of discussion. Published 2013 Wiley Periodicals, Inc. This article is a U.S. Government work and, as such, is in the public domain in the United States of America.

Entities:  

Keywords:  NMR; O-linked glycans; conformation; mucins; serine/threonine

Mesh:

Substances:

Year:  2013        PMID: 23765378     DOI: 10.1002/bip.22313

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  8 in total

1.  Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells.

Authors:  Sarah L King; Hiren J Joshi; Katrine T Schjoldager; Adnan Halim; Thomas D Madsen; Morten H Dziegiel; Anders Woetmann; Sergey Y Vakhrushev; Hans H Wandall
Journal:  Blood Adv       Date:  2017-02-23

2.  Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.

Authors:  Kristin E Haugstad; Bjørn T Stokke; C Fred Brewer; Thomas A Gerken; Marit Sletmoen
Journal:  Glycobiology       Date:  2014-12-19       Impact factor: 4.313

3.  Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.

Authors:  Souvik Biswas; Scott H Medina; Joseph J Barchi
Journal:  Carbohydr Res       Date:  2014-12-03       Impact factor: 2.104

4.  Synthesis of C-linked α-Gal and α-GalNAc-1'-hydroxyalkanes by way of C2 functionality transfer.

Authors:  Ernest G Nolen; Ezra S Hornik; Kendra B Jeans; Weiyu Zhong; Danielle M LaPaglia
Journal:  Tetrahedron Lett       Date:  2021-04-23       Impact factor: 2.032

5.  Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody.

Authors:  Nuria Martínez-Sáez; Jorge Castro-López; Jessika Valero-González; David Madariaga; Ismael Compañón; Víctor J Somovilla; Míriam Salvadó; Juan L Asensio; Jesús Jiménez-Barbero; Alberto Avenoza; Jesús H Busto; Gonçalo J L Bernardes; Jesús M Peregrina; Ramón Hurtado-Guerrero; Francisco Corzana
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-26       Impact factor: 15.336

6.  Glycosylation of Skp1 affects its conformation and promotes binding to a model f-box protein.

Authors:  M Osman Sheikh; Christopher M Schafer; John T Powell; Karla K Rodgers; Blaine H M Mooers; Christopher M West
Journal:  Biochemistry       Date:  2014-03-03       Impact factor: 3.162

Review 7.  Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.

Authors:  Dapeng Zhou; Lan Xu; Wei Huang; Torsten Tonn
Journal:  Molecules       Date:  2018-05-31       Impact factor: 4.411

8.  The Skin-Mucus Microbial Community of Farmed Atlantic Salmon (Salmo salar).

Authors:  Giusi Minniti; Live Heldal Hagen; Davide Porcellato; Sven Martin Jørgensen; Phillip B Pope; Gustav Vaaje-Kolstad
Journal:  Front Microbiol       Date:  2017-10-20       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.